0.194
price down icon5.44%   -0.0112
after-market After Hours: .19 -0.004 -2.06%
loading
Genprex Inc stock is traded at $0.194, with a volume of 3.04M. It is down -5.44% in the last 24 hours and down -33.49% over the past month. Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$0.2052
Open:
$0.206
24h Volume:
3.04M
Relative Volume:
0.35
Market Cap:
$8.32M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.0166
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-5.04%
1M Performance:
-33.49%
6M Performance:
-27.20%
1Y Performance:
-42.74%
1-Day Range:
Value
$0.17
$0.2094
1-Week Range:
Value
$0.17
$0.28
52-Week Range:
Value
$0.14
$3.97

Genprex Inc Stock (GNPX) Company Profile

Name
Name
Genprex Inc
Name
Phone
512-537-7997
Name
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Name
Employee
15
Name
Twitter
@genprex
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
GNPX's Discussions on Twitter

Compare GNPX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GNPX
Genprex Inc
0.194 8.80M 0 -22.71M -18.24M -11.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Genprex Inc Stock (GNPX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-26-21 Initiated National Securities Buy
Apr-29-19 Initiated Noble Capital Markets Outperform

Genprex Inc Stock (GNPX) Latest News

pulisher
11:30 AM

What institutional flow reveals about Genprex Inc.Market Growth Review & Low Risk High Reward Ideas - newser.com

11:30 AM
pulisher
10:58 AM

Will Genprex Inc. stock deliver consistent dividendsWeekly Trend Summary & Community Supported Trade Ideas - newser.com

10:58 AM
pulisher
10:21 AM

How to forecast Genprex Inc. trends using time seriesPortfolio Return Report & AI Powered Trade Plan Recommendations - newser.com

10:21 AM
pulisher
08:43 AM

How Genprex Inc. stock responds to policy changes2025 EndofYear Setup & Daily Growth Stock Investment Tips - newser.com

08:43 AM
pulisher
05:12 AM

Why Genprex Inc. stock is popular among millennials2025 Retail Activity & Target Return Focused Stock Picks - newser.com

05:12 AM
pulisher
Oct 09, 2025

Heatmap analysis for Genprex Inc. and competitorsJuly 2025 Catalysts & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

What to expect from Genprex Inc. in the next 30 daysJuly 2025 Breakouts & Long-Term Safe Investment Ideas - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Genprex Inc. still worth holding after the dipQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How high can Genprex Inc. stock goMarket Movers & Growth Focused Stock Pick Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Genprex Inc. stock resist market sell offsJuly 2025 Outlook & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Genprex Inc. (2DE0) stock a top hedge fund pickTrade Entry Report & High Conviction Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Analyzing net buyer seller activity in Genprex Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Risk vs reward if holding onto Genprex Inc.Market Volume Summary & Expert Curated Trade Setups - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Non-Viral Transfection Reagents Industry Report 2025, with Profiles of Altogen Biosystems, BEX, BTX, Celsion, Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene, OZ Biosciences & MoreResearchAndMarkets.com - FinancialContent

Sep 30, 2025
pulisher
Sep 30, 2025

Is Genprex Inc a good long term investmentDividend Stock Watch & Superior Wealth Strategies - earlytimes.in

Sep 30, 2025
pulisher
Sep 28, 2025

What analysts say about Genprex Inc stockRetail Investor Activity & Invest Now – Opportunity Window Closing - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc 2DE0 stock priceIPO Market Watch & Claim Your Custom Stock Report Now - earlytimes.in

Sep 27, 2025
pulisher
Sep 27, 2025

Using economic indicators to assess Genprex Inc. potentialEarnings Recap Report & Low Risk Entry Point Tips - newser.com

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Genprex Inc stock priceTechnical Breakout Signals & Free Trading Signals to Sharpen Your Edge - Early Times

Sep 27, 2025
pulisher
Sep 20, 2025

What the charts say about Genprex Inc. today2025 Technical Overview & Reliable Volume Spike Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Does Genprex Inc. fit your quant trading modelTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Applying Elliott Wave Theory to Genprex Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Genprex Inc. rebound enough to break evenQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Volatility clustering patterns for Genprex Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Can trapped investors hope for a rebound in Genprex Inc.2025 Technical Overview & Accurate Intraday Trade Tips - newser.com

Sep 18, 2025

Genprex Inc Stock (GNPX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):